Understanding mRNA Vaccines: Revolutionizing Vaccine Technology

The mRNA vaccine functions by providing our bodies with instructions on producing the virus protein and subsequently generating antibodies against it

The first type of vaccine was developed by Pfizer/BioNTech, CureVac, and Moderna, while the second was created by AstraZeneca and Janssen Pharmaceutica NV/Johnson&Johnson. The last type was developed by Sanofi-GSK. All these vaccines are administered intramuscularly.

The mRNA vaccine functions by providing our bodies with instructions on producing the virus protein and subsequently generating antibodies against it. In contrast, traditional vaccines involve administering a finished protein contained within a deactivated virus or its fragment. Previous generations of vaccines, such as those for influenza, mumps, and measles, typically contain attenuated (weakened) versions of the virus, rendering it incapable of causing disease. Developing such vaccines entails extensive research, including understanding the pathogen's genome, neutralizing processes, and formulating stable, distributable, and mass-producible vaccines. However, this approach is time-consuming. Given the urgency of developing a coronavirus vaccine, scientists turned to mRNA vaccine technology.

mRNA vaccine technology, known since the 1990s and previously used in vaccines for rabies, offers several advantages. It allows for rapid production without the need to culture the virus. Manufacturers claim that a batch of mRNA vaccine can be produced in a week, revolutionizing vaccine development compared to the six-month timeframe typically required for flu vaccines. Additionally, high-dose vaccines for children, which usually take up to 1.5 years to produce, can be expedited using this technology. mRNA vaccines also enable swift adaptation to virus mutations, ensuring continued effectiveness.

The development of multiple vaccines presents a significant opportunity for society, offering a pathway to return to normalcy through widespread vaccination. While vaccination efforts may currently be progressing slowly, adhering to governmental regulations and employing additional protective measures such as face masks is crucial to minimizing infection risks. We recommend our products - Logic Sept Disinfectant and Logic Sept Plus Disinfectant - which are safe for skin health and can further enhance protection until vaccination is achieved.

Stay healthy!